» Articles » PMID: 22396801

Critical Role of Constitutive Type I Interferon Response in Bronchial Epithelial Cell to Influenza Infection

Overview
Journal PLoS One
Date 2012 Mar 8
PMID 22396801
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Innate antiviral responses in bronchial epithelial cells (BECs) provide the first line of defense against respiratory viral infection and the effectiveness of this response is critically dependent on the type I interferons (IFNs). However the importance of the antiviral responses in BECs during influenza infection is not well understood. We profiled the innate immune response to infection with H3N2 and H5N1 virus using Calu-3 cells and primary BECs to model proximal airway cells. The susceptibility of BECs to influenza infection was not solely dependent on the sialic acid-bearing glycoprotein, and antiviral responses that occurred after viral endocytosis was more important in limiting viral replication. The early antiviral response and apoptosis correlated with the ability to limit viral replication. Both viruses reduced RIG-I associated antiviral responses and subsequent induction of IFN-β. However it was found that there was constitutive release of IFN-β by BECs and this was critical in inducing late antiviral signaling via type I IFN receptors, and was crucial in limiting viral infection. This study characterizes anti-influenza virus responses in airway epithelial cells and shows that constitutive IFN-β release plays a more important role in initiating protective late IFN-stimulated responses during human influenza infection in bronchial epithelial cells.

Citing Articles

The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment.

Farrell L, ORourke M, Padula M, Souza-Fonseca-Guimaraes F, Caramori G, Wark P Proteomes. 2024; 12(3).

PMID: 39189263 PMC: 11348234. DOI: 10.3390/proteomes12030023.


TMEM2 suppresses TLR3-mediated IFN-β/ISG56/CXCL10 expression in BEAS-2B bronchial epithelial cells.

Kobori Y, Tachizaki M, Imaizumi T, Tanaka Y, Seya K, Miki Y Mol Biol Rep. 2024; 51(1):417.

PMID: 38483660 DOI: 10.1007/s11033-024-09346-3.


Advanced models for respiratory disease and drug studies.

Shrestha J, Paudel K, Nazari H, Dharwal V, Razavi Bazaz S, Johansen M Med Res Rev. 2023; 43(5):1470-1503.

PMID: 37119028 PMC: 10946967. DOI: 10.1002/med.21956.


Impact of progesterone on innate immunity and cell death after influenza A virus H1N1 2009 infection of lung and placental cells in vitro.

Li M, Li A, Huang H, Munson J, Obadan A, Fuller D Front Virol. 2023; 2.

PMID: 36713466 PMC: 9879262. DOI: 10.3389/fviro.2022.953208.


Cdc42 regulates cytokine expression and trafficking in bronchial epithelial cells.

Shouib R, Eitzen G Front Immunol. 2023; 13:1069499.

PMID: 36618374 PMC: 9816864. DOI: 10.3389/fimmu.2022.1069499.


References
1.
. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol. 1991; 88(5):808-14. DOI: 10.1016/0091-6749(91)90189-u. View

2.
Hausmann S, Marq J, Tapparel C, Kolakofsky D, Garcin D . RIG-I and dsRNA-induced IFNbeta activation. PLoS One. 2008; 3(12):e3965. PMC: 2607022. DOI: 10.1371/journal.pone.0003965. View

3.
Qiu Y, KRUG R . The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol. 1994; 68(4):2425-32. PMC: 236720. DOI: 10.1128/JVI.68.4.2425-2432.1994. View

4.
Taniguchi T, Takaoka A . A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol. 2001; 2(5):378-86. DOI: 10.1038/35073080. View

5.
Ringold G, DIECKMANN B, Vannice J, Trahey M, McCormick F . Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells. Proc Natl Acad Sci U S A. 1984; 81(13):3964-8. PMC: 345348. DOI: 10.1073/pnas.81.13.3964. View